Inhibition of C-MYC-miRNA 19 Pathway Sensitized CML K562 Cells to Etoposide Via NHE1 Upregulation

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2022 Aug 2

PMID 35915613

Authors

Shannan Cao

Qingqing Xiong

Bowen Ding

Xu Wang

Feng Wei

Qian Sun

Fan Yang

Jing Luo

Guoqiang Chang

Suxin Li

Jian Wang

Affiliations

Soon will be listed here.

Abstract

As a previously discovered target of DNA damage, Na/H exchanger 1 (NHE1) plays a role in regulation of intracellular pH (pH) through the extrusion of intracellular proton (H) in exchange for extracellular sodium (Na). Its abnormal expression and dysfunction have been reported in solid tumor and hematopoietic malignancies. Here, we reported that suppression of NHE1 in BCR-ABL hematopoietic malignancies' K562 cells treated with Etoposide was manipulated by miR-19 and c-MYC. Inhibition of miR-19 or c-MYC enhanced the expression of NHE1 and sensitized K562 cells to Etoposide . The nude mouse transplantation model was also performed to confirm the enhanced sensitivity of K562 cells to Etoposide by inhibiting the miR-19 or c-MYC pathway. TCGA analysis conferred a negative correlation between miR-19 level and leukemia patients' survival. Thus, our results provided a potential management by which the c-MYC-miRNA 19 pathway might have a crucial impact on sensitizing K562 cells to Etoposide in the therapeutic approaches.

References

Gilbert L, Hemann M . DNA damage-mediated induction of a chemoresistant niche. Cell. 2010; 143(3):355-66. PMC: 2972353. DOI: 10.1016/j.cell.2010.09.043. View

Zhao R, Oxley D, Smith T, Follows G, Green A, Alexander D . DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH. PLoS Biol. 2006; 5(1):e1. PMC: 1702560. DOI: 10.1371/journal.pbio.0050001. View

Yang X, Wang D, Dong W, Song Z, Dou K . Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Lett. 2010; 295(2):198-204. DOI: 10.1016/j.canlet.2010.03.001. View

Lin Y, Chang G, Wang J, Jin W, Wang L, Li H . NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP. Exp Cell Res. 2011; 317(14):2031-40. DOI: 10.1016/j.yexcr.2011.05.026. View

Besson P, Yang W, Fliegel L . Regulation of Na+/H+ exchanger gene expression: mitogenic stimulation increases NHE1 promoter activity. Am J Physiol. 1998; 274(3):C831-9. DOI: 10.1152/ajpcell.1998.274.3.C831. View

Williams B, Howard R . Glucose-induced changes in Na+/H+ antiport activity and gene expression in cultured vascular smooth muscle cells. Role of protein kinase C. J Clin Invest. 1994; 93(6):2623-31. PMC: 294501. DOI: 10.1172/JCI117275. View

Baumgartner M, Patel H, Barber D . Na(+)/H(+) exchanger NHE1 as plasma membrane scaffold in the assembly of signaling complexes. Am J Physiol Cell Physiol. 2004; 287(4):C844-50. DOI: 10.1152/ajpcell.00094.2004. View

Hong L, Lai M, Chen M, Xie C, Liao R, Kang Y . The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 2010; 70(21):8547-57. PMC: 2970743. DOI: 10.1158/0008-5472.CAN-10-1938. View

Tong T, Fan W, Zhao H, Jin S, Fan F, Blanck P . Involvement of the MAP kinase pathways in induction of GADD45 following UV radiation. Exp Cell Res. 2001; 269(1):64-72. DOI: 10.1006/excr.2001.5312. View

10.

Krapf R, Pearce D, Lynch C, Xi X, Reudelhuber T, Pouyssegur J . Expression of rat renal Na/H antiporter mRNA levels in response to respiratory and metabolic acidosis. J Clin Invest. 1991; 87(2):747-51. PMC: 296370. DOI: 10.1172/JCI115057. View

11.

Cardone R, Casavola V, Reshkin S . The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer. 2005; 5(10):786-95. DOI: 10.1038/nrc1713. View

12.

Zaboikin M, Srinivasakumar N, Schuening F . Gene therapy with drug resistance genes. Cancer Gene Ther. 2005; 13(4):335-45. DOI: 10.1038/sj.cgt.7700912. View

13.

Zeller C, Hinzmann B, Seitz S, Prokoph H, Burkhard-Goettges E, Fischer J . SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer. Oncogene. 2003; 22(19):2972-83. DOI: 10.1038/sj.onc.1206474. View

14.

Deverman B, Cook B, Manson S, Niederhoff R, Langer E, Rosova I . Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell. 2002; 111(1):51-62. DOI: 10.1016/s0092-8674(02)00972-8. View

15.

Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler M . Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood. 2007; 109(10):4399-405. DOI: 10.1182/blood-2006-09-045104. View

16.

Shukla V, Coumoul X, Lahusen T, Wang R, Xu X, Vassilopoulos A . BRCA1 affects global DNA methylation through regulation of DNMT1. Cell Res. 2010; 20(11):1201-15. PMC: 9423198. DOI: 10.1038/cr.2010.128. View

17.

Orlowski J, Grinstein S . Na+/H+ exchangers of mammalian cells. J Biol Chem. 1997; 272(36):22373-6. DOI: 10.1074/jbc.272.36.22373. View

18.

Gaitanaki C, Mastri M, Aggeli I, Beis I . Differential roles of p38-MAPK and JNKs in mediating early protection or apoptosis in the hyperthermic perfused amphibian heart. J Exp Biol. 2008; 211(Pt 15):2524-32. DOI: 10.1242/jeb.018960. View

19.

Swafford A, Howson J, Davison L, Wallace C, Smyth D, Schuilenburg H . An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes. Diabetes. 2011; 60(3):1041-4. PMC: 3046822. DOI: 10.2337/db10-0446. View

20.

Izumi H, Torigoe T, Ishiguchi H, Uramoto H, Yoshida Y, Tanabe M . Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev. 2003; 29(6):541-9. DOI: 10.1016/s0305-7372(03)00106-3. View